The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of genetic testing results on patient-reported quality of life among patients undergoing panel testing for newly diagnosed ovarian cancer.
 
Sarah S. Lee
No Relationships to Disclose
 
Melissa Kristen Frey
Research Funding - Invitae (Inst)
 
Deanna Gerber
No Relationships to Disclose
 
Zachary Phillip Schwartz
No Relationships to Disclose
 
Jessica Martineau
Consulting or Advisory Role - Sema4
 
Kathleen Lutz
No Relationships to Disclose
 
Erin Reese
No Relationships to Disclose
 
Emily Dalton
Employment - Ambry Genetics
 
Anne Olsen
No Relationships to Disclose
 
Julia Girdler
No Relationships to Disclose
 
Bhavana Pothuri
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai
Research Funding - AstraZeneca (Inst); Celgene (Inst); Celsion (Inst); Clovis Oncology (Inst); Genentech (Inst); Immunogen (Inst); Merck (Inst); Takeda (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Eisai; Tesaro
 
Leslie R. Boyd
No Relationships to Disclose
 
John Patrick Curtin
Expert Testimony - Quest Diagnostics
 
Douglas A. Levine
Stock and Other Ownership Interests - Nirova BioSense
Consulting or Advisory Role - Clovis Oncology; Merck; MTrap; Tesaro
Research Funding - Splash Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patent Application US20130078319A1 - Detection of ovarian cancer; Patent application WO2015103431A9 - Compositions and methods for the diagnosis and treatment of ovarian cancers that are associated with reduced SMARCA4 gene expression or protein function
 
Stephanie V. Blank
Stock and Other Ownership Interests - Johnson & Johnson
Consulting or Advisory Role - aravive
Research Funding - Merck (Inst); Roche (Inst); Seagen (Inst); Tesaro (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca